ASIC1a mediates the drug resistance of human hepatocellular carcinoma via the Ca2 + / PI3-kinase / AKT signaling pathway
ASIC1a mediates the drug resistance of human hepatocellular carcinoma via the Ca2+/PI3-kinase/AKT signaling pathway
Laboratory Investigation 97,
53 (January 2017). doi:10.1038/labinvest.2016.127
Authors: Yihao Zhang, Ting Zhang, Chao Wu, Quan Xia & Dujuan Xu
Source: Laboratory Investigation - Category: Laboratory Medicine Authors: Yihao Zhang Ting Zhang Chao Wu Quan Xia Dujuan Xu Source Type: research
More News: Cancer & Oncology | Carcinoma | Hepatocellular Carcinoma | Laboratory Medicine | Liver Cancer